Transcatheter aortic valve replacement: focus on sex-related differences in outcomes

American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
Michael P Flaherty, Kendra J Grubb

Abstract

Transcatheter aortic valve replacement (TAVR) has transformed the management of severe aortic stenosis for high-risk and inoperable patients. The 10-year experience in Europe has proven the technology to be safe and effective in select populations. The PARTNER trial, the first prospective, randomized, controlled trial for TAVR, showed the technology to be superior to medical management for inoperable patients and equivalent to surgical aortic valve replacement for high-risk patients. Research in cardiovascular medicine has been dominated by studies on the male sex, due to the incidence of the disease process and partly due to historic predominance of male subjects in research studies. Alternatively, TAVR studies focused on high-risk and inoperable patients who are equally distributed by sex. Although sex-related differences are apparent in their baseline characteristics, outcomes have been mixed, with evidence suggesting that female patients may have a mortality advantage with TAVR. Herein we review the TAVR procedure and devices currently available and focus our discussion on outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis.

References

Nov 6, 2001·Journal of the American College of Cardiology·F H EdwardsF L Grover
Sep 27, 2006·Anesthesia and Analgesia·Andra Ibrahim DuncanNorman J Starr
Jan 20, 2009·Revista española de cardiología·Juan Caballero-BorregoEduardo de Teresa-Galván
Oct 22, 2010·The New England Journal of Medicine·Martin B LeonUNKNOWN PARTNER Trial Investigators
Apr 13, 2011·The American Journal of Cardiology·Rutger-Jan NuisPeter P de Jaegere
Jun 7, 2011·The New England Journal of Medicine·Craig R SmithUNKNOWN PARTNER Trial Investigators
Aug 3, 2011·Seminars in Thoracic and Cardiovascular Surgery·Alex WillsonJohn G Webb
Aug 20, 2011·JACC. Cardiovascular Interventions·Kentaro HayashidaMarie-Claude Morice
Sep 21, 2011·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Gill Louise BuchananAntonio Colombo
Feb 4, 2012·Journal of the American College of Cardiology·Kentaro HayashidaThierry Lefèvre
Mar 27, 2012·The New England Journal of Medicine·Raj R MakkarUNKNOWN PARTNER Trial Investigators
Mar 27, 2012·The New England Journal of Medicine·Susheel K KodaliUNKNOWN PARTNER Trial Investigators
Jul 24, 2012·Journal of the American College of Cardiology·Karin H HumphriesJohn G Webb
Jul 24, 2012·Cardiovascular Revascularization Medicine : Including Molecular Interventions·Itsik Ben-DorRon Waksman
Nov 13, 2012·Journal of Cardiothoracic and Vascular Anesthesia·Christopher ReidyJohn G T Augoustides
Sep 26, 2013·Circulation. Cardiovascular Interventions·Zhen-Gang ZhaoDe-Jia Huang
Oct 17, 2013·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Thorsten M LeuckerMichael P Flaherty
Dec 18, 2013·The American Journal of Cardiology·Aharon ErezVictor Guetta
Mar 19, 2014·Perfusion·M M RozeikT Gourlay
Mar 25, 2014·Journal of the American College of Cardiology·Jeffrey J PopmaUNKNOWN CoreValve United States Clinical Investigators
Apr 1, 2014·The New England Journal of Medicine·David H AdamsUNKNOWN U.S. CoreValve Clinical Investigators
Aug 26, 2014·The Journal of Thoracic and Cardiovascular Surgery·Michael J ReardonUNKNOWN CoreValve US Clinical Investigators
Aug 28, 2014·The American Journal of Cardiology·Federico ConrottoSebastiano Marra
Sep 4, 2014·The New England Journal of Medicine·Sanjay Kaul
Sep 11, 2014·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Michael P FlahertyGlenn A Hirsch
Sep 30, 2014·Journal of Cardiac Surgery·Yacine ElhmidiSabine Bleiziffer
Nov 26, 2014·Journal of Interventional Cardiology·Molly Szerlip, Elizabeth Holper

❮ Previous
Next ❯

Citations

May 23, 2020·Cardiology and Therapy·Ashley MohadjerKi Park

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.